Hester Biosciences Ltd (HESTERBIO) Q1FY26 Concall Summary - Jun-2025 Qtr
Performance Overview
- Hester Biosciences experienced marginal growth of 2% in the poultry segment.
- The company maintained overall turnover despite a dip in the overall market.
- Management expressed confidence in future growth and plans to gain market share.
- The Nepal plant's performance has fluctuated due to external factors like COVID-19.
- The company aims to optimize capacity across its three plants to meet rising demand, particularly in Africa.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.